Sonoma Pharmaceuticals (SNOA) EPS (Diluted) (2013 - 2026)

Sonoma Pharmaceuticals (SNOA) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.31
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -1.49
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.82
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.91
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.11
10 Sonoma Pharmaceuticals 179.80 -2.40 Mn 2.18 Mn -0.35

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.35
Dec 31, 2025 -0.48
Sep 30, 2025 -0.32
Jun 30, 2025 -0.76
Mar 31, 2025 -0.63
Dec 31, 2024 -0.63
Sep 30, 2024 -0.59
Jun 30, 2024 -1.34
Mar 31, 2024 -2.35
Dec 31, 2023 -1.59
Sep 30, 2023 -5,751.94
Jun 30, 2023 -5,740.89
Mar 31, 2023 -7,694.12
Dec 31, 2022 -12,509.68
Sep 30, 2022 -6,561.29
Jun 30, 2022 -5.72
Sep 30, 2021 -0.85
Jun 30, 2021 -10.49
Mar 31, 2021 -2,213.59
Dec 31, 2020 -233.01